Douglas E Onsi Leap Therapeutics, Inc. (LPTX) insider trading activity

LPTX Quotes by TradingView

Douglas E Onsi is CEO,CFO,Pres.,GC,Treas.&Sec. of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 106,146 shares of LPTX, which is worth approximately $36,089. The most recent transaction as insider was on Mar 28, 2025, when has been sold 32,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K
44.13% 3M change
44.13% 12M change
Total Value Held $36,089

DOUGLAS E ONSI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2025
BUY
Exercise of conversion of derivative security
-
32,500 Added 23.44%
106,146 Common Stock
Jan 26 2024
BUY
Exercise of conversion of derivative security
-
7,500 Added 9.24%
73,646 Common Stock
Mar 17 2023
BUY
Exercise of conversion of derivative security
-
660,606 Added 49.97%
661,466 Common Stock
DEO

Douglas E Onsi

CEO,CFO,Pres.,GC,Treas.&Sec.
Cambridge, MA

Track Institutional and Insider Activities on LPTX

Follow LEAP THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPTX shares.

Notify only if

Insider Trading

Get notified when an Leap Therapeutics, Inc. insider buys or sells LPTX shares.

Notify only if

News

Receive news related to LEAP THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LPTX